Lauritsen CG - Search Results

1

Ketamine for Refractory Headache: A Retrospective Analysis.

Schwenk ES, Dayan AC, Rangavajjula A, Torjman MC, Hernandez MG, Lauritsen CG, Silberstein SD, Young W, Viscusi ER. Schwenk ES, et al. Among authors: lauritsen cg. Reg Anesth Pain Med. 2018 Nov;43(8):875-879. doi: 10.1097/AAP.0000000000000827. Reg Anesth Pain Med. 2018. PMID: 29923953

2

Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.

Lauritsen C, Mazuera S, Lipton RB, Ashina S. Lauritsen C, et al. J Headache Pain. 2016 Dec;17(1):106. doi: 10.1186/s10194-016-0700-3. Epub 2016 Nov 22. J Headache Pain. 2016. PMID: 27878523 Free PMC article.

3

CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.

Yuan H, Lauritsen CG, Kaiser EA, Silberstein SD. Yuan H, et al. Among authors: lauritsen cg. BioDrugs. 2017 Dec;31(6):487-501. doi: 10.1007/s40259-017-0250-5. BioDrugs. 2017. PMID: 29116598 Review.

4

Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.

Lauritsen CG, Silberstein SD. Lauritsen CG, et al. Cephalalgia. 2019 May;39(6):750-760. doi: 10.1177/0333102418796781. Epub 2018 Aug 23. Cephalalgia. 2019. PMID: 30139273 Review.

5

Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis.

Schwenk ES, Torjman MC, Moaddel R, Lovett J, Katz D, Denk W, Lauritsen C, Silberstein SD, Wainer IW. Schwenk ES, et al. J Clin Pharmacol. 2021 Nov;61(11):1421-1429. doi: 10.1002/jcph.1920. Epub 2021 Jul 9. J Clin Pharmacol. 2021. PMID: 34125442 Free PMC article.

6

Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.

Mojica JJ, Schwenk ES, Lauritsen C, Nahas SJ. Mojica JJ, et al. Curr Pain Headache Rep. 2021 Dec 11;25(12):77. doi: 10.1007/s11916-021-00992-x. Curr Pain Headache Rep. 2021. PMID: 34894295 Free PMC article. Review.

7

Lidocaine infusions for refractory chronic migraine: a retrospective analysis.

Schwenk ES, Walter A, Torjman MC, Mukhtar S, Patel HT, Nardone B, Sun G, Thota B, Lauritsen CG, Silberstein SD. Schwenk ES, et al. Among authors: lauritsen cg. Reg Anesth Pain Med. 2022 Jul;47(7):408-413. doi: 10.1136/rapm-2021-103180. Reg Anesth Pain Med. 2022. PMID: 35609890

8

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis.

Yuan H, Natekar A, Park J, Lauritsen CG, Viscusi ER, Marmura MJ. Yuan H, et al. Among authors: lauritsen cg. Reg Anesth Pain Med. 2023 Dec;48(12):581-587. doi: 10.1136/rapm-2022-104223. Epub 2023 May 30. Reg Anesth Pain Med. 2023. PMID: 37253638

9

Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.

Wang VS, Kosman J, Yuan H, Lauritsen C, Shrewsbury S, Aurora SK, Hopkins M, Silberstein S. Wang VS, et al. Headache. 2023 Oct;63(9):1251-1258. doi: 10.1111/head.14636. Epub 2023 Sep 23. Headache. 2023. PMID: 37740562

10

Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Lauritsen CG, Chua AL, Nahas SJ. Lauritsen CG, et al. Curr Treat Options Neurol. 2018 Mar 6;20(4):7. doi: 10.1007/s11940-018-0492-7. Curr Treat Options Neurol. 2018. PMID: 29508091 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page